Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elena Petersen is active.

Publication


Featured researches published by Elena Petersen.


Nano Research | 2015

Cytotoxicity and non-specific cellular uptake of bare and surface-modified upconversion nanoparticles in human skin cells

Anna E. Guller; Alla N. Generalova; Elena Petersen; Andrey V. Nechaev; Inna Trusova; Nikolay N. Landyshev; Annemarie Nadort; Ekaterina A. Grebenik; Sergey M. Deyev; Anatoly B. Shekhter; Andrei V. Zvyagin

The cytotoxicity and non-specific cellular uptake of the most popular composition of upconversion nanoparticle (UCNP), NaYF4:Yb3+:Er3+, is reported using normal human skin cells, including dermal fibroblasts and immortalized human epidermal linear keratinocytes (HaCaT). A new hydrophilization reaction of as-synthesized UCNPs based on tetramethylammonium hydroxide (TMAH) enabled evaluation of the intrinsic cytotoxicity of bare UCNPs. The cytotoxicity effects of the UCNP surface-coating and polystyrene host were investigated over the concentration range 62.5–125 μg/mL with 24-h incubation, using a MTT test and optical microscopy. The fibroblast viability was not compromised by UCNPs, whereas the viability of keratinocytes varied from 52% ± 4% to 100% ± 10% than the control group, depending on the surface modification. Bare UCNPs reduced the keratinocyte viability to 76% ± 3%, while exhibiting profound non-specific cellular uptake. Hydrophilic poly(D,L-lactide)- and poly(maleic anhydride-alt-1-octadecene)-coated UCNPs were found to be least cytotoxic among the polymer-coated UCNPs, and were readily internalized by human skin cells. Polystyrene microbeads impregnated with UCNPs remained nontoxic. Surprisingly, no correlation was found between UCNP cytotoxicity and the internalization level in cells, although the latter ranged broadly from 0.03% to 59%, benchmarked against 100% uptake level of TMAH-UCNPs.


Clinical Lymphoma, Myeloma & Leukemia | 2017

Non-Covalent Conjugation of Antibodies and Lentiviruses to Nanoparticles as a Potential Tool for Gene Therapy

Alexey Petukhov; Konstantin G. Shevchenko; Alexandra Daks; Tatyana Leonova; Alexey Titov; Evgeny Smirnov; Ekaterina Zaikova; Elena Petersen; Dmitry Motorin; Andrey Zaritskey; Maxim P. Nikitin

S394 treatment received, information on the diagnosis/treatment received abroad. Diagnosis delay was defined as the time between the patient’s first symptom recognition to a diagnosis of cancer. Patients: We reviewed and analyzed the charts of the patients’ 18 years old with hematologic malignancies diagnosed and treated at the Clinic of Chemotherapy of Muratsan Hospital Complex of Yerevan State Medical University between 2008 and 2012. Results: During mentioned period of time 33 children with hematologic malignancies were diagnosed and treated at our clinic, from which 20 (61%) were patients with acute lymphoblastic leukemia, 4 (12%) patients with Hodgkin lymphoma and 9 (27%) with Non-Hodgkin lymphoma. From 33 patients information on immunophenotyping was available for 30 (91%), from which only 13 (43%) had the immuopheotyping performed at diagnosis. 14 (42%) patients received part of diagnosis and/or treatment abroad. The most frequent diagnostic/treatment procedure was bone marrow transplantation, otherwise none available in Armenia. 27 (81%) patients had information on diagnosis delay. The median time of diagnosis delay for the group was 42 days (range [1346 days]). The longest delay was reported in Hodgkin lymphoma cases. Conclusions: This single-institution report shows significant therapeutic and diagnostic limitations, as well as diagnosis delay for pediatric hematologic malignancies in Armenia. Larger studies are needed to further explore the contributing factors.


SPIE BioPhotonics Australasia | 2016

Onion-like surface design of upconverting nanophosphors modified with polyethylenimine: shielding toxicity versus keeping brightness?

Anna E. Guller; Annemarie Nadort; Alla N. Generalova; Inna Kornienko; Elena Petersen; Yi Qian; Anatoly B. Shekhter; Ewa M. Goldys; Andrei V. Zvyagin

Background: Upconverting nanoparticles (UCNPs) represent a unique class of nanomaterials, able to convert infrared excitation light into long lifetime visible and infrared photoluminescence, within the “optical transparency window” of biological tissues. This makes UCNPs an attractive contrast agent for background-free bioimaging. However, assynthesized UCNPs are hydrophobic and need additional surface coating for stability in water-based solutions and further functionalization. Polyethylenimine (PEI), a polycationic amphiphilic polymer, is a well-known transfection agent for gene delivery and a popular material for UCNPs surface hydrophilization. Combining the functional properties of UCNPs and PEI is extremely useful for precise visualization of genetic manipulations and intracellular drug delivery. At the same time, PEI is toxic to cells, while the photoluminescent properties of UCNPs are very sensitive to surface chemistry and environment. Then, creation of hydrophilic, biocompatible and simultaneously bright UCNPs, modified by PEI (UCNP-PEI), is a challenging task. Objectives: To analyze the effects of multilayer shielding coatings on cytotoxicity, cellular uptake and photoluminescent properties of UCNP-PEI. Methods and results: UCNP-PEI were modified with additional two or three layers of various polymers and characterized by size, surface charge and photophysical properties. HaCaT keratinocytes were exposed to the particles for 24 or 120 h to study the cytotoxicity and cellular uptake. The results show that onion-like coatings of UCNP-PEI simultaneously decrease cytotoxicity and relative luminescence of the particles, depending on structure and method of formation of multilayer coating. Conclusions: Rational design of UCNP-PEI using extra coatings layers can help to keep acceptable levels of biocompatibility and photoluminescence intensity.


SPIE Micro+Nano Materials, Devices, and Applications Symposium | 2015

Acellular organ scaffolds for tumor tissue engineering

Anna E. Guller; Inna Trusova; Elena Petersen; Anatoly B. Shekhter; Alexander Kurkov; Yi Qian; Andrei V. Zvyagin

Rationale: Tissue engineering (TE) is an emerging alternative approach to create models of human malignant tumors for experimental oncology, personalized medicine and drug discovery studies. Being the bottom-up strategy, TE provides an opportunity to control and explore the role of every component of the model system, including cellular populations, supportive scaffolds and signalling molecules. Objectives: As an initial step to create a new ex vivo TE model of cancer, we optimized protocols to obtain organ-specific acellular matrices and evaluated their potential as TE scaffolds for culture of normal and tumor cells. Methods and results: Effective decellularization of animals’ kidneys, ureter, lungs, heart, and liver has been achieved by detergent-based processing. The obtained scaffolds demonstrated biocompatibility and growthsupporting potential in combination with normal (Vero, MDCK) and tumor cell lines (C26, B16). Acellular scaffolds and TE constructs have been characterized and compared with morphological methods. Conclusions: The proposed methodology allows creation of sustainable 3D tumor TE constructs to explore the role of organ-specific cell-matrix interaction in tumorigenesis.


ACS Biomaterials Science & Engineering | 2018

Rational Surface Design of Upconversion Nanoparticles with Polyethylenimine Coating for Biomedical Applications: Better Safe than Brighter?

Anna E. Guller; Annemarie Nadort; Alla N. Generalova; E. V. Khaydukov; Andrey V. Nechaev; Inna Kornienko; Elena Petersen; Liuen Liang; Anatoly B. Shekhter; Yi Qian; Ewa M. Goldys; Andrei V. Zvyagin


World Academy of Science, Engineering and Technology, International Journal of Bioengineering and Life Sciences | 2017

Comparison of Physical and Chemical Effects on Senescent Cells

Svetlana Guryeva; Inna Kornienko; Andrey Usanov; Dmitry A. Usanov; Elena Petersen


World Academy of Science, Engineering and Technology, International Journal of Bioengineering and Life Sciences | 2017

Consumption and Diffusion Based Model of Tissue Organoid Development

Elena Petersen; Inna Kornienko; Svetlana Guryeva; Sergey Simakov


World Academy of Science, Engineering and Technology, International Journal of Bioengineering and Life Sciences | 2017

Prospects of Low Immune Response Transplants Based on Acellular Organ Scaffolds

Inna Kornienko; Svetlana Guryeva; Anatoly B. Shekhter; Elena Petersen


World Academy of Science, Engineering and Technology, International Journal of Bioengineering and Life Sciences | 2017

Prospects of Acellular Organ Scaffolds for Drug Discovery

Inna Kornienko; Svetlana Guryeva; Natalia Danilova; Elena Petersen


World Academy of Science, Engineering and Technology, International Journal of Bioengineering and Life Sciences | 2017

Determining Cellular Biomarkers Sensitive to Low Damaging Exposure

Svetlana Guryeva; Inna Kornienko; Elena Petersen

Collaboration


Dive into the Elena Petersen's collaboration.

Top Co-Authors

Avatar

Inna Kornienko

Moscow Institute of Physics and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anatoly B. Shekhter

I.M. Sechenov First Moscow State Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yi Qian

Macquarie University

View shared research outputs
Top Co-Authors

Avatar

Alla N. Generalova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Inna Trusova

Moscow Institute of Physics and Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge